Skip to main content
Toggle navigation
Tech
Culture
Brain
Body
Heavens
Earth
Home
Feed aggregator
RAS(ON) inhibitor doubles median overall survival in results of phase 3 trial for patients with metastatic pancreatic cancer
FetchEureka
-
May 31 2026 - 15:05
(Feed generated with
FetchRSS
)
Categories:
Content
first
previous
…
19
20
21
22
23
24
25
26
27
